Gene Therapy for Type 2 Diabetes Enters Human Trial ...

Encoded Therapeutics gives a heads-up to other gene therapy company about the trade-offs with a drug meant to improve safety.

D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage devel ...

Some in the gene therapy field lament lost time while Capsida kept silent about the brain receptor it was targeting when ...

Fractyl Health, Inc. reported past first quarter 2026 results showing net income of US$9.22 million and earnings of US$0.06 per share from continuing operations, reversing a prior-year loss. A day ...

The therapies are incredible, says Will Shrank, M.D. They can “totally transform the lives of those who can benefit.” But ...

Dr. Marty Makary noted it had "record speed approval," the fastest approval of any gene therapy device combination in U.S.

CRISPR gene therapy increases haemoglobin and fetal haemoglobin in sickle cell disease, reducing vaso occlusive events in ...

There is a new game changer for children with a certain form of muscular dystrophy. Now, a child who was destined to end up ...

Detalimogene voraplasmid lead to numerous durable complete responses with favorable safety ...

A breakthrough FDA-approved treatment is changing how genetic deafness is treated.

The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both pediatric and adult patients after positive results.